Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013681449> ?p ?o ?g. }
- W2013681449 endingPage "856" @default.
- W2013681449 startingPage "847" @default.
- W2013681449 abstract "The present study determined the effects of chronic recombinant human nerve growth factor administration [1 μg given intracerebroventricularly q.i.d. (every other day) for three weeks] on in vivo hippocampal cholinergic function in adult rats with unilateral partial fimbrial transections. Partial fimbrial transections did not significantly alter the levels of endogenous acetylcholine or [2H4]acetylcholine in the hippocampus due to functional compensation by surviving cholinergic terminals. In animals chronically treated with nerve growth factor, the levels of endogenous choline, endogenous acetylcholine, [2H4]choline and [2H4]acetylcholine accumulated in the hippocampus on the lesioned side were not significantly different from those on the contralateral unlesioned side or from values measured in animals treated with cytochrome c, a control protein. However, changes in cholinergic parameters induced by the partial lesions or recombinant human nerve growth factor treatment became manifest when animals were challenged using pharmacological agents such as pentylenetetrazole or pilocarpine given after lithium chloride pretreatment. First, in nerve growth factor-treated animals administered the general stimulant pentylenetetrazole (10 mg/kg) 2 min prior to measuring in vivo cholinergic parameters, we observed a significant increase in the hippocampal content of [2H4]choline in both lesioned and unlesioned hippocampi. The magnitude of the increase was significantly higher on the lesioned compared to the unlesioned side. Although chronic recombinant human nerve growth factor treatment induced increases of hippocampal [2H4]choline levels, there were no concomitant increases in the level of [2H4]acetylcholine. Second, in nerve growth factor-treated animals administered lithium chloride (3 mmol/kg) 20 h prior to pilocarpine (30 mg/kg), we observed a significant enhancement of the content of endogenous acetylcholine in the hippocampus of the lesioned side. Partial fimbrial transections also reduced in vitro cholinergic parameters reflecting endogenous acetylcholine levels in hippocampal slices. The content of endogenous acetylcholine in the slices was decreased by approximately 50% and chronic nerve growth factor treatment significantly elevated this value to approximately non-lesioned control values. Similarly, reductions in spontaneous and veratridine-evoked release of endogenous acetylcholine induced by partial fimbrial transections were counteracted by recombinant human nerve growth factor treatment. These findings demonstrate that chronic recombinant human nerve growth factor treatment effectively enhances the in vivo and in vitro synthesis, storage and release of endogenous acetylcholine. The results from the in vivo studies suggest that recombinant human nerve growth factor-induced differences in functional performance of hippocampal neurons may only be manifest during behavioral and/or pharmacological stimulation." @default.
- W2013681449 created "2016-06-24" @default.
- W2013681449 creator A5054270816 @default.
- W2013681449 creator A5060081589 @default.
- W2013681449 creator A5078952307 @default.
- W2013681449 date "1992-10-01" @default.
- W2013681449 modified "2023-09-23" @default.
- W2013681449 title "Pharmacological stimulation reveals recombinant human nerve growth factor-induced increases of in vivo hippocampal cholinergic function measured in rats with partial fimbrial transections" @default.
- W2013681449 cites W1502570337 @default.
- W2013681449 cites W1565785673 @default.
- W2013681449 cites W1609471181 @default.
- W2013681449 cites W1898295630 @default.
- W2013681449 cites W1966019489 @default.
- W2013681449 cites W1987391780 @default.
- W2013681449 cites W1990964837 @default.
- W2013681449 cites W1991566402 @default.
- W2013681449 cites W1991712654 @default.
- W2013681449 cites W1994067502 @default.
- W2013681449 cites W1994938162 @default.
- W2013681449 cites W1999385494 @default.
- W2013681449 cites W2001382455 @default.
- W2013681449 cites W2004368602 @default.
- W2013681449 cites W2004933246 @default.
- W2013681449 cites W2010844256 @default.
- W2013681449 cites W2016098200 @default.
- W2013681449 cites W2040700904 @default.
- W2013681449 cites W2042757803 @default.
- W2013681449 cites W2043650944 @default.
- W2013681449 cites W2045848174 @default.
- W2013681449 cites W2048754703 @default.
- W2013681449 cites W2072169153 @default.
- W2013681449 cites W2074785038 @default.
- W2013681449 cites W2091011317 @default.
- W2013681449 cites W2093413350 @default.
- W2013681449 cites W2094220775 @default.
- W2013681449 cites W2143158156 @default.
- W2013681449 cites W2166771846 @default.
- W2013681449 cites W2328317502 @default.
- W2013681449 cites W272340338 @default.
- W2013681449 cites W88851328 @default.
- W2013681449 doi "https://doi.org/10.1016/0306-4522(92)90208-j" @default.
- W2013681449 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1448201" @default.
- W2013681449 hasPublicationYear "1992" @default.
- W2013681449 type Work @default.
- W2013681449 sameAs 2013681449 @default.
- W2013681449 citedByCount "21" @default.
- W2013681449 crossrefType "journal-article" @default.
- W2013681449 hasAuthorship W2013681449A5054270816 @default.
- W2013681449 hasAuthorship W2013681449A5060081589 @default.
- W2013681449 hasAuthorship W2013681449A5078952307 @default.
- W2013681449 hasConcept C104966671 @default.
- W2013681449 hasConcept C126322002 @default.
- W2013681449 hasConcept C134018914 @default.
- W2013681449 hasConcept C148762608 @default.
- W2013681449 hasConcept C150903083 @default.
- W2013681449 hasConcept C170493617 @default.
- W2013681449 hasConcept C185592680 @default.
- W2013681449 hasConcept C207001950 @default.
- W2013681449 hasConcept C22885893 @default.
- W2013681449 hasConcept C2775910092 @default.
- W2013681449 hasConcept C2778423431 @default.
- W2013681449 hasConcept C2781123555 @default.
- W2013681449 hasConcept C2781161787 @default.
- W2013681449 hasConcept C71924100 @default.
- W2013681449 hasConcept C86803240 @default.
- W2013681449 hasConceptScore W2013681449C104966671 @default.
- W2013681449 hasConceptScore W2013681449C126322002 @default.
- W2013681449 hasConceptScore W2013681449C134018914 @default.
- W2013681449 hasConceptScore W2013681449C148762608 @default.
- W2013681449 hasConceptScore W2013681449C150903083 @default.
- W2013681449 hasConceptScore W2013681449C170493617 @default.
- W2013681449 hasConceptScore W2013681449C185592680 @default.
- W2013681449 hasConceptScore W2013681449C207001950 @default.
- W2013681449 hasConceptScore W2013681449C22885893 @default.
- W2013681449 hasConceptScore W2013681449C2775910092 @default.
- W2013681449 hasConceptScore W2013681449C2778423431 @default.
- W2013681449 hasConceptScore W2013681449C2781123555 @default.
- W2013681449 hasConceptScore W2013681449C2781161787 @default.
- W2013681449 hasConceptScore W2013681449C71924100 @default.
- W2013681449 hasConceptScore W2013681449C86803240 @default.
- W2013681449 hasIssue "4" @default.
- W2013681449 hasLocation W20136814491 @default.
- W2013681449 hasLocation W20136814492 @default.
- W2013681449 hasOpenAccess W2013681449 @default.
- W2013681449 hasPrimaryLocation W20136814491 @default.
- W2013681449 hasRelatedWork W1977150341 @default.
- W2013681449 hasRelatedWork W1982378996 @default.
- W2013681449 hasRelatedWork W1994626701 @default.
- W2013681449 hasRelatedWork W2004617417 @default.
- W2013681449 hasRelatedWork W2035792930 @default.
- W2013681449 hasRelatedWork W2049823274 @default.
- W2013681449 hasRelatedWork W2070061431 @default.
- W2013681449 hasRelatedWork W2081720076 @default.
- W2013681449 hasRelatedWork W2084582389 @default.
- W2013681449 hasRelatedWork W760396034 @default.
- W2013681449 hasVolume "50" @default.
- W2013681449 isParatext "false" @default.
- W2013681449 isRetracted "false" @default.